Gene-chip analysis of the effect of tripeptide tyroservatide (YSV) on gene-expression in human hepatocarcinoma BEL-7402 tumors transplanted to nude mice

Molecular Carcinogenesis

Volumn 45, Issue 3, 2006, Pages 197-203

  Jia, Jing ^a   Lu, Rong ^a,b   Zhou, Chunlei ^a   Zhao, Lan ^a   Fu, Zheng ^a   Zhu, Zhitong ^a   Wang, Li ^a   Zheng, Minna ^a   Yang, Jing ^a   Zhang, Yanjun ^a   Yao, Zhi ^a,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Pharmaped Research and Development (Shenzhen) Limited   (China)

^c TIANJIN UNIVERSITY   (China)

Author keywords

Antitumor; Gene chip; Histone; Nude mice

Indexed keywords

HISTONE; SERINE; TRIPEPTIDE; TYROSINE; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CELL KILLING; CHROMOSOME; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; MICROCHIP ANALYSIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGOPEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; MUS MUSCULUS;

EID: 33644822040     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20172     Document Type: Article

References (30)

1. Janin YL. Peptides with anticancer use or potential. Amino Acids 2003;25:1-40.
2. Jia J, Lu R, Qiu S, et al. Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402. Cancer Biol Ther 2005;4: [Epub ahead of print].
3. Jing J, Zhitong Z, Rong L, et al. Experimental study on the inhibiting mechanism of Tyroservaltide to human hepatocarcinoma BEL-7402 proliferation. Chinese Pharmacological Bulletin 2005;9: (in press).
4. Ono K, Tanaka T, Tsunoda T, et al. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res 2000;60:5007-5011.
5. B. DeLange RJ, Smith EL. Histones: Structure and function. Annu Rev Biochem 1971;40:279-314.
6. Han Y. Research and development of anticancer drugs and experimental techniques (1st edition) Beijing: Peking University Health Center and Peking Union Medical College Publishing House; 1997. 299p.
7. Bumol TF, Watanabe AM. Genetic information, genomic technologies, and the future of drug discovery. JAMA 2001;285:551-555.
8. Erkan M, Kleeff J, Esposito I, et al. Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 2005;24: 4421-4432.
9. Zaffaroni N, Pennati M, Colella G, et al. Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Life Sci 2002;59:1406-1412.
10. Ito M, Nakashima M, Nakayama T, et al. Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around chernobyl. Thyroid 2002;12:971-975.
11. Saxena N. Differential expression of WISP-1 and WISP-2 genes in normal and transformed human breast cell lines. Mol Cell Biochem 2001;228:99-101.
12. Abdollahi A, Pisarcik D, Roberts D, Weinstein J, Cairns P, Hamilton TC. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. J Biol Chem 2003;278:6041-6049.
13. Koul D, Shen R, Garyali A, Ke LD, Liu TJ, Yung WK. MMAC/ PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol 2002;21:469-475.
14. Ayala G, Thompson T, Yang G, et al. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence. Clin Cancer Res 2004;10:6572-6578.
15. Goriounov D, Leung CL, Liem RK. Protein products of human Gas2-related genes on chromosomes 17 and 22 (hGAR17 and hGAR22) associate with both microfilaments and microtubules. J Cell Sci 2003;116:1045-1058.
16. Hake SB, Xiao A, Allis CD. Linking the epigenetic 'language' of covalent histone modifications to cancer. Br J Cancer 2004;90:761-769.
17. Andrae J, Molander C, Smits A, Funa K, Nister M. Platelet-derived growth factor-B and -C and active alpha-receptors in medulloblastoma cells. Biochem Biophys Res Commun 2002;296:604-611.
18. Kessel JM, Gern JE, Vrtis RF, Sedgwick JB, Busse WW. Ligation of intercellular adhesion molecule 3 inhibits GM-CSF production by human eosinophils. J Allergy Clin Immunol 2003;111:1024-1031.
19. Fu Z, Lu R, Li GL, et al. Tyroserleutide tripeptide affects calcium homeostasis of human hepatocarcinoma BEL-7402 cells. Sci China C Life Sci 2005;35:262-268.
20. Qiu S, Lu R, Zhao L, et al. Experimental study on anti-tumor effects of tripeptide tyroserleutide and its mechanisms by activating monocyte-macrophages. Chin J Cancer Biotherapy 2005;12:129-133.
21. Strachan T, Abitbol M, Davidson D, Beckmann JS. A new dimension for the human genome project: Towards comprehensive expression maps. Nat Genet 1997;16:126-132.
22. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-1828.
23. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000;403:41-45.
24. Leffak IM. Conservative segregation of nucleosome core histones. Nature 1984;307:82-85.
25. Losa R, Thoma F, Koller T. Involvement of the globular domain of histone H1 in the higher order structures of chromatin. J Mol Biol 1984;175:529-551.
26. Plumb M, Stein J, Stein G. Influence of DNA synthesis inhibition on the coordinate expression of core human histone genes during S phase. Nucleic Acids Res 1983;11: 7927-7945.
27. Stein GS, Stein JL. Is human histone gene expression autogenously regulated? Mol Cell Biochem 1984;64:105-110.
28. Ko SG, Lee KS, Cho KH, Kim YS, Bae HS, Moon SK. Inhibition of human smooth muscle cell proliferation by gamigeonsimtang through the transcriptional regulation of cell cycle-controlling genes. Am J Chin Med 2000;28:57-67.
29. Vaisanen S, Dunlop TW, Frank C, Carlberg C. Using chromatin immunoprecipitation to monitor 1alpha,25-dihydroxyvitamin Dα3-dependent chromatin activity on the human CYP24 promoter. J Steroid Biochem Mol Biol 2004; 89-90:277-279.
30. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074-1080.